Issue 6, 2012

An amino-benzosuberene analogue that inhibits tubulin assembly and demonstrates remarkable cytotoxicity

Abstract

The recent discovery of a small-molecule benzosuberene-based phenol that demonstrates remarkable picomolar cytotoxicity against selected human cancer cell lines and strongly inhibits tubulin polymerization (1–2 μM) inspired the design and synthesis of a variety of new, structurally diverse benzosuberene derivatives. An efficient synthetic route to functionalized benzosuberenes was developed. This methodology utilized a Wittig reaction, followed by a selective alkene reduction and ring-closing cyclization to form the core benzosuberone structure. This synthetic route facilitated the preparation of a 4-nitro-1-(3′,4′,5′-trimethoxyphenyl) benzosuberene derivative and its corresponding 4-amino analogue in good yield. The 4-amino analogue was a strong inhibitor of tubulin polymerization (1.2 μM), demonstrated enhanced cytotoxicity against the human cancer cell lines examined (GI50 = 33 pM against SK-OV-3 ovarian cancer, for example), and exhibited a concentration dependent disruption of a pre-established capillary-like network of tubules formed from human umbilical vein endothelial cells.

Graphical abstract: An amino-benzosuberene analogue that inhibits tubulin assembly and demonstrates remarkable cytotoxicity

Supplementary files

Article information

Article type
Concise Article
Submitted
26 Dec 2011
Accepted
10 Feb 2012
First published
21 Mar 2012

Med. Chem. Commun., 2012,3, 720-724

An amino-benzosuberene analogue that inhibits tubulin assembly and demonstrates remarkable cytotoxicity

R. P. Tanpure, C. S. George, M. Sriram, T. E. Strecker, J. K. Tidmore, E. Hamel, A. K. Charlton-Sevcik, D. J. Chaplin, M. L. Trawick and K. G. Pinney, Med. Chem. Commun., 2012, 3, 720 DOI: 10.1039/C2MD00318J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements